These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Significance of tumor markers in the treatment of cancer: hematologic malignancy]. Sampi K Gan To Kagaku Ryoho; 1987 Nov; 14(11):3041-5. PubMed ID: 3674891 [TBL] [Abstract][Full Text] [Related]
3. The role of recombinant interleukin-2 in therapy for hematologic malignancies. Dutcher JP; Wiernik PH Semin Oncol; 1993 Dec; 20(6 Suppl 9):33-40. PubMed ID: 8284690 [No Abstract] [Full Text] [Related]
5. [Autologous graft of bone marrow in hematology. Development of concepts]. Hervé P Ann Med Interne (Paris); 1986; 137(2):89-91. PubMed ID: 3521432 [No Abstract] [Full Text] [Related]
6. [Bone marrow transplantation in blood diseases and neoplasms]. Robak T Postepy Hig Med Dosw; 1985; 39(5):465-517. PubMed ID: 3915351 [No Abstract] [Full Text] [Related]
7. Clinical and managed care issues in blood and marrow transplantation for hematologic diseases. Report of a symposium, 14 March 1996, Washington, DC. Beatty PG Exp Hematol; 1997 Oct; 25(11):1195-208. PubMed ID: 9328457 [No Abstract] [Full Text] [Related]
8. [Association between malignant hematologic diseases and cancer]. Jakó J; Nagy P; Dauda G; Szerafin L; Francz M; László A; Smanykó D Orv Hetil; 1994 Nov; 135(47):2585-90. PubMed ID: 7824257 [TBL] [Abstract][Full Text] [Related]
9. A treatment for oral precancerous lesions: why do we not yet have a treatment? Lozada-Nur F Med Oral Patol Oral Cir Bucal; 2009 Apr; 14(4):E159-62. PubMed ID: 19333182 [No Abstract] [Full Text] [Related]
10. [Hematology: biomedical discipline and interdiscipline constantly updated]. Berceanu S Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(1):1-9. PubMed ID: 2899342 [No Abstract] [Full Text] [Related]
11. Biotherapy with interferon in hematologic malignancies. Roth MS; Foon KA Oncol Nurs Forum; 1987; 14(6 Suppl):16-22. PubMed ID: 2447569 [No Abstract] [Full Text] [Related]
12. [Status and trends in hematology]. Stobbe H Z Arztl Fortbild (Jena); 1986; 80(18):741-4. PubMed ID: 3544527 [No Abstract] [Full Text] [Related]
13. Allogeneic bone marrow transplantation in the treatment of hematologic diseases. Yee GC; McGuire TR Clin Pharm; 1985; 4(2):149-60. PubMed ID: 3886273 [TBL] [Abstract][Full Text] [Related]
14. International Meeting on the Therapy of Hematological Malignancies in the Elderly. Proceedings. Turin, 15-16 April 1993. Hematol Oncol; 1993; 11 Suppl 1():1-84. PubMed ID: 8486335 [No Abstract] [Full Text] [Related]
15. What's new in haematology? Hounsell J; Isbister JP Med J Aust; 1994 Jan; 160(1):38-40. PubMed ID: 8271984 [No Abstract] [Full Text] [Related]
17. [Perspectives for the use of gene therapy in blood disorders]. Jedrzejczak WW Pol Arch Med Wewn; 2002 May; 107(5):475-9. PubMed ID: 12189921 [No Abstract] [Full Text] [Related]
18. [Current possibilities and prospects in hematologic diseases]. Berceanu S Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1980; 32(6):481-6. PubMed ID: 6113667 [No Abstract] [Full Text] [Related]
19. [Experience in the ambulatory care of patients with hematologic diseases at the Hematology Day Hospital]. Belić A; Kljajić D; Uzurov V; Savić I Med Pregl; 1989; 42(11-12):431-3. PubMed ID: 2642202 [TBL] [Abstract][Full Text] [Related]
20. Cytostatic treatment of haemoblastoses and associated conditions. NETOUSEK M Cesk Onkol; 1956; 3(3):240-50. PubMed ID: 13396823 [No Abstract] [Full Text] [Related] [Next] [New Search]